During the past decade, Hospital Kuala Lumpur; Jabatan Radioterapi dan Onkologi conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital Kuala Lumpur; Jabatan Radioterapi dan Onkologi" are "Carcinoma, Non-Small-Cell Lung" (1 trials), "Gastric Cancer" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Hospital Kuala Lumpur; Jabatan Radioterapi dan Onkologi" in a lesser frequency.

Most popular intervention types in "Hospital Kuala Lumpur; Jabatan Radioterapi dan Onkologi" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (2 trials), "Placebo" (2 trials), "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials) and "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Kuala Lumpur; Jabatan Radioterapi dan Onkologi" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Kuala Lumpur; Jabatan Radioterapi dan Onkologi". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital Kuala Lumpur; Jabatan Radioterapi dan Onkologi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Kuala Lumpur; Jabatan Radioterapi dan Onkologi, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".